Home Cardiorespiratory Monitoring
Summary
Home cardiorespiratory monitoring may be considered medically necessary when initiated in infants younger than 12 months of age who have tracheostomies or anatomic abnormalities that make them vulnerable to airway compromise, who have neurologic or metabolic disorders affecting respiratory control including central apnea and apnea of prematurity, or who have bronchopulmonary dysplasia. Home cardiorespiratory monitoring used as a strategy to reduce the risk of Sudden Infant Death Syndrome, used for cardiopulmonary evaluation in lower-risk infants following a brief resolved unexplained event, and used in all other conditions including the diagnosis of obstructive sleep apnea are considered investigational. An update dated 10/15/2026 changed the medically necessary criteria wording from chronic lung disease to bronchopulmonary dysplasia.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.